Submitted by Anonymous (not verified) on 30 November 2023 - 11:57
Human medicines European public assessment report (EPAR): Thalidomide BMS (previously Thalidomide Celgene), thalidomide, Multiple Myeloma, Date of authorisation: 16/04/2008, Revision: 31, Status: Authorised
Source: